Streeck Hendrik, Lichterfeld Mathias, Alter Galit, Meier Angela, Teigen Nickolas, Yassine-Diab Bader, Sidhu Harlyn K, Little Susan, Kelleher Anthony, Routy Jean-Pierre, Rosenberg Eric S, Sekaly Rafick-Pierre, Walker Bruce D, Altfeld Marcus
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02129, USA.
J Virol. 2007 Jul;81(14):7725-31. doi: 10.1128/JVI.00708-07. Epub 2007 May 9.
Human immunodeficiency virus type 1 (HIV-1)-specific immune responses during primary HIV-1 infection appear to play a critical role in determining the ultimate speed of disease progression, but little is known about the specificity of the initial HIV-1-specific CD8(+) T-cell responses in individuals expressing protective HLA class I alleles. Here we compared HIV-1-specific T-cell responses between subjects expressing the protective allele HLA-B27 or -B57 and subjects expressing nonprotective HLA alleles using a cohort of over 290 subjects identified during primary HIV-1 infection. CD8(+) T cells of individuals expressing HLA-B27 or -B57 targeted a defined region within HIV-1 p24 Gag (amino acids 240 to 272) early in infection, and responses against this region contributed over 35% to the total HIV-1-specific T-cell responses in these individuals. In contrast, this region was rarely recognized in individuals expressing HLA-B35, an HLA allele associated with rapid disease progression, or in subjects expressing neither HLA-B57/B27 nor HLA-B35 (P < 0.0001). The identification of this highly conserved region in p24 Gag targeted in primary infection specifically in individuals expressing HLA class I alleles associated with slower HIV-1 disease progression provides a rationale for vaccine design aimed at inducing responses to this region restricted by other, more common HLA class I alleles.
在原发性人类免疫缺陷病毒1型(HIV-1)感染期间,HIV-1特异性免疫反应似乎在决定疾病进展的最终速度方面起着关键作用,但对于表达保护性HLA I类等位基因的个体中初始HIV-1特异性CD8(+) T细胞反应的特异性了解甚少。在此,我们使用一组在原发性HIV-1感染期间确定的290多名受试者,比较了表达保护性等位基因HLA-B27或-B57的受试者与表达非保护性HLA等位基因的受试者之间的HIV-1特异性T细胞反应。表达HLA-B27或-B57的个体的CD8(+) T细胞在感染早期靶向HIV-1 p24 Gag内的一个特定区域(氨基酸240至272),针对该区域的反应在这些个体的总HIV-1特异性T细胞反应中占比超过35%。相比之下,在表达与疾病快速进展相关的HLA等位基因HLA-B35的个体中,或者在既不表达HLA-B57/B27也不表达HLA-B35的受试者中,该区域很少被识别(P < 0.0001)。在原发性感染中,特别是在表达与HIV-1疾病进展较慢相关的HLA I类等位基因的个体中,鉴定出p24 Gag中这个高度保守的靶向区域,为旨在诱导受其他更常见HLA I类等位基因限制的针对该区域反应的疫苗设计提供了理论依据。